Jennifer Schranz is Chief Medical Officer at Nabriva Therapeutics plc (NBRV). They have made 1 open-market trade across 1 company since 2018, most recently 2021-02-28.
CIK 0001735382
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $21K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBRV | 39,125 | $56K |
Shares reported on the most recent Form 4, priced at the 2021-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBRV | BUY | 2018-06-22 | 2018-06-25 | $3.73 | $21K | -9.4% | -7.3% | -34.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.